Aptamer Details

Back to Search Results

VEGF-stimulated HUVECs (ID# 7622)

* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.

Aptamer Chemistry: Peptide

Target: VEGF-stimulated human umbilical vein endothelial cells (HUVECs)

Antigen/Target Category: Tissue

Affinity (Kd): N/A nM (reported value)

Binding Conditions/Buffer: In vivo mice.

Binding Temp: N/A°C

Refolding Protocol: NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.

Comments: See also PVV peptide , which also results in tumor growth suppression.
See also DRW peptide , which contains the same WRP epitope resulting in suppression of tumor growth.

Sequence ():

Length: 15

Molecular Weight: 2017.31

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Reference:

Asai et al. "Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels." FEBS Letters, 510(2002): 206-210.

Have your aptamer oligo synthesized ORDER